Skip to main content

[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑧ | Interview with James Cho, Head of Overseas Business Department, Humedix

 At IMCAS World Congress 2026, we sat down with James Cho, Head of the Overseas Business Department at Humedix. The company is diversifying its export structure — previously anchored in China and Brazil — into Europe, the Middle East, and Southeast Asia, led by its flagship HA filler Elravie Premier. Brazil has posted three consecutive years of export growth. Humedix is currently preparing for CE MDR certification with a target completion of 2028 to establish a foothold in the European market, while a new PN-compound filler is also nearing launch, signaling accelerated growth through portfolio expansion. From the shifting export landscape to global KOL collaboration strategies and the company's mid-to-long-term vision, this interview covers it all. 

#MedicalAestheticNews #IMCAS2026 #Humedix #ElraviePremier


★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11209



Labels:

Comments

Post a Comment

Popular posts from this blog

[Hands-On] The Power of Quasar Tension from the Scalp! Full-Face ‘SUNNY’ Lifting by Dr. Hyungdon Yoon_Part 1

 Dr. Hyungdon Yoon of Toxnfill Clinic Gangdong Cheonho has released a hands-on demonstration video showcasing his treatment techniques using the Quasar Tip of SUNNY, the premium RF lifting device by SHENB. As the No. 1 user of the Virtue RF tip for two consecutive years (2023 and 2024), Dr. Yoon now highlights the core principles of SUNNY and demonstrates his most effective treatment strategies. According to Dr. Yoon, the Quasar Tip delivers precise targeting and deep thermal energy, working directly on the facial ligaments to regenerate stretched ligaments and create a natural lifting effect. Notably, SUNNY is the first RF device capable of treating the scalp, allowing practitioners to strengthen the scalp ligaments and support the entire face from above — a unique and innovative approach. Dr. Yoon emphasizes that SUNNY improves elasticity without reducing fat, enabling vertical facial shortening and enhanced horizontal lifting without concerns of volume loss. He also highlights t...
Post a Comment
Read more

Less Pain, Longer Results — The Evolution of Skin Booster Injectors, Derma Shine Duo RF

 Dr. Hoyeon Choi of Clim Clinic is actively utilizing a new multi-needle injector that combines radiofrequency (RF) technology with skin booster treatments. According to Dr. Choi, this device adds RF functionality to the conventional multi-needle injector, creating synergistic effects in drug delivery, skin texture improvement, elasticity enhancement, and extended duration of results. He also highlighted reduced drug loss and less pain compared to manual injections as key advantages. Furthermore, he noted that when combined with existing monopolar RF or HIFU devices, the elasticity improvement effects become even more pronounced, making it a highly recommended option especially for international patients who cannot visit frequently. #MedicalAestheticNews #HuonsMeditech #DermaShine_Duo_RF #ClimClinic_Myeongdong #Dr_HoYeon_Choi ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=10960
Post a Comment
Read more

VAIM Demonstrates JUVELOOK's Competitive Edge at JP Morgan Conference Two-session presentations draw recognition from global industry professionals

 VAIM was invited as the only Korean company to speak at two sessions of the JP Morgan Healthcare Conference, the world's largest healthcare investment symposium, showcasing the technological prowess of K-medical aesthetics. At the event held in San Francisco from January 12-15, co-CEOs Jonghyeon Park and Donghoon Jeon presented VAIM's flagship product JUVELOOK and mid- to long-term growth strategy at the Beyond K-Beauty session and Investor Presentation session. CEO Jeon emphasized JUVELOOK's differentiated technology, stating that "the Korean beauty industry is leading the global trend toward natural beauty." Since its 2019 launch, JUVELOOK has surpassed 2 million vials in cumulative production and is expanding into 72 countries worldwide. VAIM announced that it will continue to strengthen its position in the global medical aesthetics market based on its proven technological competitiveness. #MedicalAestheticNews #VAIM #JUVELOOK #LENISNA ★ Article Link: https://...
Post a Comment
Read more